SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Koilpillai Mano S

(Last) (First) (Middle)
7380 IRA SEARS ROAD

(Street)
ADAMSTOWN MD 21710

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/26/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/26/2021 M 2,631(1) A $40.15 2,631 D
Common Stock 04/26/2021 S 2,631(2) D $50.16 0 D
Common Stock 04/27/2021 M 702(3) A $40.15 702 D
Common Stock 04/27/2021 S 522(4) D $49.94 180 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option to Purchase Common Stock $40.15 04/26/2021 M 2,631 12/23/2020 12/23/2029 Common Stock 2,631 $40.15 27,369(5) D
Stock Option to Purchase Common Stock $40.15 04/27/2021 M 702 12/23/2020 12/23/2029 Common Stock 702 $40.15 26,667(5) D
Explanation of Responses:
1. On April 26, 2021, the Reporting Person exercised her stock option received on December 23, 2019 to purchase 2,631 shares of the Issuer's common stock at a price of $40.15 per share.
2. On April 26, 2021, the Reporting Person sold 2,631 shares of common stock on the open market at an average price of $50.16 per share.
3. On April 27, 2021, the Reporting Person exercised her stock option received on December 23, 20219 to purchase 702 shares of the Issuer's common stock at a price of $40.15 per share.
4. On April 27, 2021 the Reporting Person sold 522 shares of common stock on the open market at an average price of $49.94 per share.
5. As of the date of this filing, the Reporting Person owns options to purchase (a) 10,000 shares of common stock at a price of $42.31 per share with initial Date Exercisable of 9/10/2020 and Expiration Date of 9/10/2029; (b) 6,667 shares of common stock at a price of $40.15 per share with initial Date Exercisable of 12/23/2020 and Expiration Date of 12/23/2029; and (c) 10,000 shares of common stock at a price of $45.75 per share with initial Date Exercisable of 12/14/2021 and Expiration Date of 12/14/2030, all of which vest ratably over three years on the anniversary of each grant date.
/s/ Mano S Koilpillai 04/28/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.